Patient Enrollment to Industry-Sponsored Versus Federally-Sponsored Cancer Clinical Trials
In the United States, there is a growing reliance on industry to conduct cancer clinical research. Underinvestment in federally-sponsored research comes at a cost for both patients and researchers, with lost opportunities for scientific, clinical, and population advances.
Authors
- Michael LeBlanc (ORCID: https://orcid.org/0000-0001-7192-2860)
- Hong Xiao (ORCID: https://orcid.org/0000-0002-5113-2367)
- Riha Vaidya (ORCID: https://orcid.org/0000-0001-5316-6352)
- Joseph M. Unger (ORCID: https://orcid.org/0000-0002-5191-0317)
Institutions
- Fred Hutch Cancer Center (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1200/jco.24.00843
- Citations
- 22
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 7.18